Astec LifeSciences Limited — Important, 02-07-2025: Committee Meeting Updates

Astec LifeSciences Limited has announced a board meeting on the proposed Rights Issue of up to 28.02 lakh equity shares at ₹890 per share, targeting approximately ₹249.35 Cr. The issue ratio is 1 new share for every 7 shares held by eligible shareholders. The Letter of Offer has been approved and filed, providing shareholders an opportunity to increase their stake through this significant capital raise aimed at strengthening the company’s financial profile. The full details are available on the company’s website.